Načítá se...
Glutamatergic Modulators in Depression
Both preclinical and clinical studies have implicated glutamatergic system dysfunction in the pathophysiology of mood disorders such as bipolar depression and major depressive disorder (MDD). In particular, rapid reductions in depressive symptoms have been noted in response to subanesthetic doses of...
Uloženo v:
| Vydáno v: | Harv Rev Psychiatry |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6102095/ https://ncbi.nlm.nih.gov/pubmed/29465478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HRP.0000000000000183 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|